Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
Belmusto-Worn VE, Sanchez JL, McCarthy K, Nichols R, Bautista CT, Magill AJ, Pastor-Cauna G, Echevarria C, Laguna-Torres VA, Samame BK, Baldeon ME, Burans JP, Olson JG, Bedford P, Kitchener S, Monath TP. Belmusto-Worn VE, et al. Among authors: kitchener s. Am J Trop Med Hyg. 2005 Feb;72(2):189-97. Am J Trop Med Hyg. 2005. PMID: 15741556 Clinical Trial.
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Guirakhoo F, Kitchener S, Morrison D, Forrat R, McCarthy K, Nichols R, Yoksan S, Duan X, Ermak TH, Kanesa-Thasan N, Bedford P, Lang J, Quentin-Millet MJ, Monath TP. Guirakhoo F, et al. Among authors: kitchener s. Hum Vaccin. 2006 Mar-Apr;2(2):60-7. doi: 10.4161/hv.2.2.2555. Epub 2006 Mar 15. Hum Vaccin. 2006. PMID: 17012873 Clinical Trial.
Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis.
Edstein MD, Nasveld PE, Kocisko DA, Kitchener SJ, Gatton ML, Rieckmann KH. Edstein MD, et al. Among authors: kitchener sj. Trans R Soc Trop Med Hyg. 2007 Mar;101(3):226-30. doi: 10.1016/j.trstmh.2006.04.003. Epub 2006 Jun 30. Trans R Soc Trop Med Hyg. 2007. PMID: 16814823 Clinical Trial.
Adequate primaquine for vivax malaria.
Kitchener S, Nasveld P, Bennett S, Torresi J. Kitchener S, et al. J Travel Med. 2005 May-Jun;12(3):133-5. doi: 10.2310/7060.2005.12306. J Travel Med. 2005. PMID: 15996441 Free article.
Treatment of acute vivax malaria with tafenoquine.
Nasveld P, Kitchener S. Nasveld P, et al. Among authors: kitchener s. Trans R Soc Trop Med Hyg. 2005 Jan;99(1):2-5. doi: 10.1016/j.trstmh.2004.01.013. Trans R Soc Trop Med Hyg. 2005. PMID: 15550254
63 results